| Literature DB >> 35713363 |
JunYuan Bai1, XiaoWei Pu1, YunXia Zhang1, Enlai Dai2.
Abstract
OBJECTIVE: The present study identified novel renal tubular biomarkers that may influence the diagnosis and treatment of focal segmental glomerulosclerosis (FSGS) based on immune infiltration.Entities:
Keywords: Focal segmental glomerulosclerosis; dual specificity phosphatase 1; immune infiltrates; machine learning; nuclear receptor subfamily 4 group A member 1; tubular
Mesh:
Substances:
Year: 2022 PMID: 35713363 PMCID: PMC9225740 DOI: 10.1080/0886022X.2022.2081579
Source DB: PubMed Journal: Ren Fail ISSN: 0886-022X Impact factor: 3.222
The differentially expressed genes in tubular cells between FSGS and normal controls.
| DEGS | Genes name |
|---|---|
| Down-regulated | CYP4A22, FOS, ERRFI1, EGF, KLK1, CYP4Z1, PDK4, ALB, SNORD14E, MIR612, MT1A, DNAJB3, IFIT1B, SNORA11,NR4A1, TRPM6, ZBTB16, SNORD59A, SNORA14A, SCN3A,FKBP5, MIR221, SCARNA4, MRO, SNORD104, IP6K3, NDNF,DUSP1, CYP3A5, MTNR1A, RGS1, MT1E, ESM1, SNORD82,TIPARP, LOC644090, NR4A3, EGR1, PCOLCE2, LINC00853,LINC00473, APOH, PTPRQ, TUBGCP3, FNDC9, DEPDC1B, SLC12A3, SLC25A33, SNORD59B ,FAM24B,TMEM207, RGS2, SLED1, GGACT, SORCS1, ZBTB20-AS1,GADD45B, HRG, SNORD71, ZMAT1, KLHL3, CYP2B6,NUGGC, CYP27B1, GABARAPL1, SNORA79, PTPRO, AFM,SNORD67, N4BP2L2-IT2, CHI3L1, DPY19L2, LEFTY1, CEL, FOSB, SNORA81,CCNL1, SNORA31, CLCNKA |
| Up-regulated | CAPN6, CST6, LRRN4, APOBEC3G, CPA3, MPEG1, RNASE6,CD40, PLP2, LCP2, FN1, FLT3, FHL3, CD2, CD48, LCP1, C2, OAS3, CD53, CD180, SPIN2B, IFITM1, SLAMF7, APOBEC3F,UCP2, FXYD5, TLR7, IFI6, ZYX, WFDC2, EMP3, LGALS1,HLA-DQA1, C1R, IGLV4-69, ARPC1B, PXDN, TIMP1, TNC,TOP2A, IGHV3-15, SLC43A3, TMEM54, GPX8, PLTP, BGN,IFNAR2, HSPB6, CCL11, THBS2, SFRP2, IGLV3-25, CD37, MFAP4, HPGDS,TRBV29-1, HAVCR1, FCER1G, TYROBP,COL6A3, IL2RG, C1S, LAPTM5, GZMA, CTSS, APOC1,CYBB,COL3A1,TGM2,CCL5,C1QC,IGLV2-18, IGHV3-33,SLC34A2,IGKC, MOXD1, LCN2, LTF, IGHG4, SAA1, IGKV1-27, CCL21,C3, MMP7, CCL19, CD52, IGLC7, IGKV1-17, HBB, HBA2,IGHM, IGKV2D-24, VCAN, IGKV4-1, SLPI, IGHA1, IGKV3-11, HBA1, LYZ, REG1A |
Figure 1.DEGs in tubular cells between FSGS and normal controls. (a) The heatmap shows significant DEGs between FSGS and normal controls. The X-axis represents the sample type, and the Y-axis represents the DEGs. (b) Volcano plot exhibiting DEGs between FSGS and normal controls, downregulated genes and upregulated genes. The X-axis represents the logFC, and the Y-axis represents the -log10 (adj. P.Val). P values < 0.05 indicate statistical significance. DEGs: differentially expressed genes.
The related diseases of the differentially expressed genes.
| Term | Genes | Count | |
|---|---|---|---|
| DOID:2349-Arteriosclerosis | LYZ,HBA1,EGF,CD40,LGALS1,FN1,CHI3L1,KLK1,CCL5,TNC,PLTP,CTSS, UCP2,ALB,APOH,APOC1,SAA1 | 17 | 0.0007 |
| DOID:557-Kidney disease | DUSP1,FOS,COL3A1,MT1A,CYP3A5,EGF,CD40,RGS2,TIMP1,FN1,CHI3L1, KLK1,CCL5,PTPRO,HLA-DQA1,C3,ALB,HAVCR1,LCN2 | 19 | 0.0007 |
| DOID:2348-Arteriosclerotic cardiovascular disease | LYZ,HBA1,EGF,CD40,LGALS1,FN1,CHI3L1,CCL5,TNC,PLTP,CTSS,UCP2, ALB,APOH,APOC1,SAA1 | 16 | 0.0007 |
| DOID:18-urinary system disease | DUSP1,FOS,COL3A1,MT1A,CYP3A5,EGF,CD40,RGS2,TIMP1,FN1,CHI3L1, KLK1,CCL5,PTPRO,HLA-DQA1,C3,ALB,HAVCR1,LCN2PTPRO,HLA-DQA1, C3,ALB,HAVCR1,LCN2 | 19 | 0.0007 |
| DOID:120-female reproductive organ cancer | DUSP1,CCNL1,TGM2,FOS,EGF,VCAN,CD40,TIMP1,CHI3L1,KLK1,IFITM1,MMP7, HLA-DQA1,TOP2A,SLPI,CCL11,LCN2,WFDC2 | 18 | 0.001 |
| DOID:1936-atherosclerosis | HBA1,EGF,CD40,LGALS1,FN1,CHI3L1,CCL5,TNC,PLTP,CTSS,UCP2,ALB, APOH,APOC1,SAA1 | 15 | 0.0016 |
| DOID:10952-nephritis | DUSP1,COL3A1,MT1A,CD40,KLK1,CCL5,PTPRO,HLA-DQA1,LCN2 | 9 | 0.005 |
| DOID:2916-hypersensitivity reaction type IV disease | COL3A1,TIMP1,CHI3L1,TNC,HLA-DQA1,HAVCR1,IGKC | 7 | 0.0054 |
| DOID:1037-lymphoblastic leukemia | MIR221,BGN,CYP3A5,CD40,PTPRO,CD52,MMP7,TOP2A,TLR7,CCL21,ALB, CCL11,CCL19,IGHM,CD2,FLT3 | 16 | 0.0054 |
| DOID:2394-ovarian cancer | DUSP1,TGM2,FOS,EGF,VCAN,TIMP1,CHI3L1,KLK1,MMP7,HLA-DQA1, CCL11,LCN2,WFDC2 | 13 | 0.0054 |
Figure 2.DO enrichment analysis revealed the relationship between DEGs and associated diseases. The significantly associated diseases were visualized through a barplot. The X-axis represents the number of genes enriched in each disease, and the Y-axis represents the disease name. p values < 0.05 indicate statistical significance. DO: disease ontology; DEGS: differentially expressed genes.
Figure 3.GSEA was used to perform DEG-related GO enrichment analyses. The results of GO analyses revealed the biological functional pathways significantly enriched in tubular cells from the FSGS group (a) and the control group (b), especially in BP annotation. The X-axis represents the rank in the ordered dataset, and the Y-axis represents the running enrichment score. p values < 0.05 indicate statistical significance. GSEA: gene set enrichment analysis; GO: gene ontology; BP: biological process.
Figure 4.GSEA was used to perform DEG-related KEGG enrichment analyses. The results of the KEGG analyses revealed the signaling pathways significantly enriched in tubular cells from the FSGS group (a) and the control group (b). The X-axis represents the rank in the ordered dataset, and the Y-axis represents the running enrichment score. P values < 0.05 indicate statistical significance. GSEA: gene set enrichment analysis; KEGG: kyoto encyclopedia of genes and genomes.
Figure 6.Submodule construction and KEGG pathway enrichment analysis of submodules. The three key modules screened from the PPI network using the MCODE method with a score ≥ 3 and genes ≥ 4 were identified as submodules. (a) shows module 1 with an MCODE score of 3.778, (b) shows module 2 with an MCODE score of 3.333, and (c) shows module 3 with an MCODE score of 3.333. (d–f) show the top 7 functional pathways associated with the genes in modules 1–3 through KEGG pathway enrichment analysis. The X-axis represents the gene ratio, and the Y-axis represents the significantly enriched KEGG pathways of the module. p values < 0.05 indicate statistical significance. KEGG: kyoto encyclopedia of genes and genomes; PPI: protein-protein interaction; MCODE: molecular complex detection.
Figure 7.LASSO model and SVM-RFE were used to mine the gene biomarkers of FSGS. (a) Nineteen genes were extracted as gene biomarkers of FSGS via LASSO regression. (b) Six genes were extracted as gene biomarkers of FSGS using the SVM-RFE algorithm. (c) A total of 2 overlapping genes between LASSO regression and the SVM-RFE algorithm were identified. LASSO: least absolute shrinkage and selection operator; SVM-RFE: support vector machine recursive feature elimination.
Figure 8.The present study utilized the GSE125779 Series Matrix File to validate the levels of expression of the two characteristics, renal tubular samples of the control group and renal tubular samples of the FSGS group. (a) DUSP1 (b) NR4A1. The X-axis represents the sample grouping, and the Y-axis represents the target gene expression. p values < 0.05 indicate statistical significance. DUSP1: dual specificity phosphatase 1; NR4A1: nuclear receptor subfamily 4 group A member 1.
Figure 9.ROC curve analyses were used to investigate the logistic regression model. (a) DUSP1 (b) NR4A1. The X-axis represents the (1-specificity), and the Y-axis represents the sensitivity. P values < 0.05 indicate statistical significance. ROC: Receiver operating characteristic; DUSP1: dual specificity phosphatase 1; NR4A1: nuclear receptor subfamily 4 group A member 1.
Figure 10.The GSE125779 Series Matrix File was used to validate the logistic regression model via ROC. (a) DUSP1 (b) NR4A1. The X-axis represents the (1-specificity), and the Y-axis represents the sensitivity. P values < 0.05 indicate statistical significance. ROC: Receiver operating characteristic; DUSP1: dual specificity phosphatase 1; NR4A1: nuclear receptor subfamily 4 group A member 1.
Figure 12.The relationship between the two selected genes and infiltrating immune cells. (a) DUSP1. (b) NR4A1. The X-axis represents the correlation coefficient, and the Y-axis represents the immune cells. p values < 0.05 indicate statistical significance. DUSP1: dual specificity phosphatase 1; NR4A1: nuclear receptor subfamily 4 group A member 1.